Although new immunosuppressive agents have greatly improved the post-transplantation survival, their adverse effects remain a major challenge. Appropriate assessment and monitoring the immune status in post-transplantation patients is therefore essential. This article summarizes the monitoring indicators and reviews recent advances in this field.